CXCL12 has been found to mediate protection of B-ALL cells from chemotherapeutic agents, with B-ALL cells upregulating CXCR4 expression in response to chemotherapy [112]. This evidence concerns the gene CXCL12 and acute lymphoblastic leukemia.